Skip to main content
Publication date
2017 Nov 11
Authors
Huh, WK Joura, EA Giuliano, AR Iversen, OE de Andrade, RP Ault, KA Bartholomew, D Cestero, RM Fedrizzi, EN Hirschberg, AL Mayrand, MH Ruiz-Sternberg, AM Stapleton, JT Wiley, DJ Ferenczy, A Kurman, R Ronnett, BM Stoler, MH Cuzick, J Garland, SM Kjaer, SK Bautista, OM Haupt, R Moeller, E Ritter, M Roberts, CC Shields, C Luxembourg, A
Author KI Usernames
Hirschberg, AL|anghir
Pubmed ID
28886907
Journal
Lancet (London, England)
Doctype
Article
KI Connection
Låg
Mesh SV
Behandlingsresultat Dosrelaterad effekt av läkemedel Dubbelblindmetod Humant papillomvirus 6 Immunanalys Injektioner, intramuskulära Kvinnlig Livmoderhalstumörer Människa Papillomvirusinfektioner Patientföljsamhet Patientsäkerhet Primärprevention Unga vuxna Ungdomar Uppföljningsstudier Vaccination Vaccinimmunogenitet Virusantikroppar Vuxna
Mesh EN
Antibodies, Viral Dose-Response Relationship, Drug Double-Blind Method Follow-Up Studies Human papillomavirus 6 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Immunoassay Immunogenicity, Vaccine Injections, Intramuscular Papillomavirus Infections Patient Compliance Patient Safety Primary Prevention Treatment Outcome Uterine Cervical Neoplasms Vaccination
First date
2017-12-10T10:45:34.465Z